Viewing Study NCT04547985



Ignite Creation Date: 2024-05-06 @ 3:10 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04547985
Status: TERMINATED
Last Update Posted: 2023-10-24
First Post: 2020-08-31

Brief Title: Naltrexone Treatment for Prolonged Grief Disorder PGD
Sponsor: Weill Medical College of Cornell University
Organization: Weill Medical College of Cornell University

Study Overview

Official Title: Naltrexone Treatment for Prolonged Grief Disorder A Pilot Study
Status: TERMINATED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: We are terminating the study due to low accrual
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PGD
Brief Summary: This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder PGD Participants will take their assigned medication for 8 weeks with monthly visits to assess symptom severity social connectedness and adverse reactions
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None